What are peptide bioregulators?
The concept originated in the 1970s with Soviet military medical research led by Vladimir Khavinson and colleagues in St. Petersburg. The team extracted peptide fractions from animal organs and reported that each fraction preferentially affected the corresponding organ in the recipient.[1]
Two generations of compounds came out of that work:
- Natural peptide extracts — complex mixtures purified from animal tissue, such as Thymalin (thymus) and Cortexin (brain cortex).
- Synthetic short peptides — defined two-to-four-amino-acid sequences designed to reproduce the active part of those extracts, such as Epitalon (AEDG) and Vilon (KE).
The proposed mechanism is unusual: rather than binding a surface receptor like a typical peptide hormone, these peptides are said to be small enough to enter the cell nucleus and interact directly with DNA, switching specific genes on or off.[2] Published work reports changes in gene expression and protein synthesis in cell cultures consistent with that idea.[3]
The main bioregulator peptides
Each bioregulator is associated with a target organ. The table below gives the sequence where it is a defined synthetic peptide, and what it has been studied for.
| Bioregulator | Target tissue | Studied for |
|---|---|---|
| Epitalon (AEDG) | Pineal gland | The most-discussed of the group — melatonin rhythm, telomerase activity, and lifespan in animal models[4] |
| Thymalin | Thymus | Immune function and cell differentiation[5] |
| Thymogen (EW) | Thymus | The synthetic dipeptide counterpart of Thymalin |
| Vilon (KE) | Thymus / immune | Immune modulation and ageing markers |
| Pinealon (EDR) | Brain | Neuroprotection and cognitive function in animal models |
| Cortexin | Brain cortex | Used clinically in Russia for brain injury and cognitive impairment |
| Vesugen (KED) | Blood vessels | Vascular endothelium |
| Cardiogen (AED) | Heart | Cardiac muscle |
| Thymulin | Thymus | A distinct zinc-dependent thymic hormone, not a Khavinson peptide, but often grouped with them |
Several also appear in our anti-aging, cognitive, and immune support categories.
An honest look at the evidence
This is the section that matters most, because bioregulators are frequently marketed with the phrase "over 40 years of research" — which is true, and also incomplete.
What genuinely exists: decades of published work, including animal lifespan experiments, cell-culture gene-expression studies, and clinical use of Thymalin and Cortexin within Russia and the CIS.[1][5]
The serious caveats:
- Single-source concentration. An overwhelming share of the literature comes from Khavinson and closely associated collaborators. Independent replication by unaffiliated groups is scarce — and independent replication is the mechanism by which science corrects itself.
- Publication venue. Much of it appears in Russian-language or low-circulation journals, with limited peer review exposure outside that network.
- Trial quality. The human studies are generally small and often lack the randomization, blinding, and placebo controls expected of modern trials.
- No FDA approval. None of these compounds is approved in the United States. Products sold online are unapproved and unregulated for purity or sterility.
- Extraordinary claims. Reported effects on lifespan and telomerase are exactly the kind of claim that demands independent confirmation, and that confirmation has not materialized.
The fair summary: a real and internally consistent research programme, not yet validated by the wider scientific community. That is a different verdict from either "proven" or "pseudoscience." For how we weigh claims like these, see how peptide research is graded.
Common questions about form and legality
Bioregulators are sold in two very different formats, which causes a lot of confusion:
- Oral capsules are the most commonly marketed form. This is chemically notable — most peptides are destroyed by digestion, and the claim that these very short chains survive intact enough to act is one of the least independently verified parts of the theory.
- Injectable preparations are what most of the underlying clinical research on Thymalin and Cortexin actually used.
Legally, Cortexin and Thymalin are registered medicines in Russia and some neighbouring countries, but nothing in this group is FDA-approved in the US, where these are unapproved compounds. See are peptides legal? and are peptides safe?
Frequently asked questions
What are peptide bioregulators?
Peptide bioregulators, or Khavinson peptides, are very short peptides of two to four amino acids proposed to act as organ-specific regulators of gene expression. Each is associated with the tissue it was derived from, such as Epitalon with the pineal gland and Thymalin with the thymus.
What are Khavinson peptides?
They are named after Vladimir Khavinson, the Russian researcher whose St. Petersburg group developed them from the 1970s onward. The term covers both the natural organ extracts like Thymalin and the synthetic short peptides like Epitalon and Vilon.
Do peptide bioregulators actually work?
The evidence is unresolved. Decades of published research exist, but it comes overwhelmingly from one research lineage, is often published in Russian-language journals, and has seen little independent replication. None is FDA-approved.
What is a pineal bioregulator?
That usually refers to Epitalon (AEDG), a synthetic four-amino-acid peptide derived from a pineal gland extract. It has been studied in animals for effects on melatonin rhythm, telomerase activity, and lifespan, but human evidence is limited.
Are bioregulator peptides taken orally or by injection?
Both forms are sold. Most of the underlying clinical research used injections, while the capsules widely marketed today rely on the contested claim that these very short peptides survive digestion intact.
Are peptide bioregulators legal?
Cortexin and Thymalin are registered medicines in Russia and some neighbouring countries. None of the group is FDA-approved in the United States, where they are sold only as unapproved research compounds. Legality depends on your country.
Further reading
Selected peer-reviewed sources on this topic, labelled by type. A citation is a reference, not an endorsement.
- Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002. Peer-reviewed study
- Khavinson VK, Lin'kova NS, Tarnovskaya SI. Short Peptides Regulate Gene Expression. Bull Exp Biol Med. 2016. Peer-reviewed study
- Ashapkin V, Khavinson V, Shilovsky G, et al. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Mol Biol Rep. 2020. Peer-reviewed study
- Araj SK, Brzezik J, Mądra-Gackowska K, et al. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025. Peer-reviewed study
- Khavinson VK, Linkova NS, Kvetnoy IM, et al. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bull Exp Biol Med. 2020. Peer-reviewed study